Interestingly, genetic studies have identified the PNPLA3-I148M variant as a prominent genetic factor associated with NAFLD, and even more prominently with disease progression within NAFLD to NASH and NASH-associated cirrhosis [49,50,51]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.